Mode
Text Size
Log in / Sign up

Turner syndrome

Part of Heart Defects, Congenital

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Turner syndrome

8 trials tracked for Turner syndrome: 7 in phase 3 or 4 and 1 with published results. The most-cited published study has 36 citations.

8Trials tracked
7Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 5 Phase 3 2 Other / NA 1
  1. Phase 4 Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN® Completed · 36 cited
  2. Phase 4 Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome Completed
  3. Phase 4 Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism Completed
  4. Phase 4 First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study Completed
  5. Phase 4 Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents Completed
  6. Phase 3 Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq Completed
Show 2 more trials
  1. Phase 3 Somatropin Treatment to Final Height in Turner Syndrome Completed
  2. N/A Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.